Illumina CEO: Seeing big growth in genomic testing

Francis deSouza, Illumina president and CEO, talks about what's driving the company's growth, the unveiling of its $20,000 desktop sequencer and the future of genome sequencing.
04:14
Tue, Jan 9 20188:39 AM EST